BNET Industries
Last Fiscal Year Sales:$21.4M
- Public
- US
Dow Jones Description
Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or with partners including seven clinical compounds in Phase 2 or Phase 1 development addressing hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic alliances with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals.
Number of Employees 169
Peer Companies
NAICS Code Research and Development in the Social Sciences and Humanities: 541720
News & Analysis
Filter by
pharmacopeia drug discovery inc. - All News and Analysis
Pharmacopeia Drug Discovery Inc. Plans to Sell Shares.
- 2007-04-25
M2 PRESSWIRE-25 April 2007-NASDAQNEWS: Pharmacopeia Drug Discovery Inc. Plans to Sell SharesC1994-2007 M2 COMMUNICATIONS LTD RDATE:25042007 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you have a...
Morning Alert for Pharmacopeia Drug Discovery Inc.
- 2007-04-25
M2 PRESSWIRE-25 April 2007-Biotech News: Morning Alert for Pharmacopeia Drug Discovery Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:25042007 Pharmacopeia Drug Discovery PDD provides drug discovery services for pharmaceutical and biotechnology companies. These services include lead discovery and optimization, as well as collaborative R&D...
In- Depth Research on Pharmacopeia Drug Discovery Inc.
- 2007-04-11
M2 PRESSWIRE-11 April 2007-Biotech News: In- Depth Research on Pharmacopeia Drug Discovery IncC1994-2007 M2 COMMUNICATIONS LTD RDATE:11042007 In- Depth Research on Pharmacopeia Drug Discovery Inc (NASDAQ:PCOP) Pharmacopeia Drug Discovery, Inc., a biopharmaceutical company, engages in the discovery and development...
BellwetherReport.com Issues Alert for Pharmacopeia Drug Discovery Inc.
- 2006-05-23
M2 PRESSWIRE-23 May 2006-bellwetherreport.com: BellwetherReport.com Issues Alert for Pharmacopeia Drug Discovery Inc.C1994-2006 M2 COMMUNICATIONS LTD RDATE:23052006 The Bellwether Report Takes Notice of Pharmacopeia Drug Discovery Inc. (Nasdaq:PCOP) Pharmacopeia Drug Discovery PDD, formerly a unit of Pharmacopeia Inc., provides drug discovery...
Responds to Market Activity for Pharmacopeia Drug Discovery Incorporated.
- 2006-03-31
M2 PRESSWIRE-31 March 2006-marketgainer.com: Responds to Market Activity for Pharmacopeia Drug Discovery IncorporatedC1994-2006 M2 COMMUNICATIONS LTD RDATE:30032006 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets....
Pharmacopeia to Present at Windhover Information's Euro-Biotech Forum 2005
- 2005-06-01
PARIS -- Pharmacopeia Drug Discovery, Inc. (Nasdaq: PCOP) has announced that it will be presenting at 9:05am CET on June 3rd at Windhover Information's Euro-Biotech Forum 2005, taking place June 1-3 in Paris, France. Pharmacopeia Drug Discovery, Inc. (www.pharmacopeia.com) is a biopharmaceutical company focused on the creation of new...
Pharmacopeia forms macular degeneration agreement with Allergan.
- 2005-06-01
Pharmacopeia Drug Discovery, Inc. (Princeton, NJ) has entered into an agreement with Allergan, Inc. (Irvine, CA) to evaluate proprietary active lead compounds, discovered at Pharmacopeia, in models of ocular disease. The agreement resulted in an upfront cash payment from Allergan to Pharmacopeia, and...
Biovitrum AB and Pharmacopeia Drug Discovery Inc sign strategic alliance agreement
- 2004-10-26
NORDIC BUSINESS REPORT-26 October 2004-Biovitrum AB and Pharmacopeia Drug Discovery Inc sign strategic alliance agreementC1994-2004 M2 COMMUNICATIONS LTD http://www.m2.com The Swedish biotech company Biovitrum AB said on Tuesday (26 October) that it had signed a strategic alliance agreement with the US company Pharmacopeia Drug Discovery Inc. The companies...
In May, Pharmacopeia completed its spinoff of Pharmacopeia Drug Discovery and Pharmacopeia and PDD began trading separately on the Nasdaq
- 2004-07-31
In May, Pharmacopeia completed its spinoff of Pharmacopeia Drug Discovery PDD (see IBO 12/31/03) and Pharmacopeia and PDD began trading separately on the Nasdaq. Pharmacopeia changed its name to Accelrys and appointed Mark Emkjer, previously president of Accelrys, as president and CEO.
- 1
Industry Transcripts by Seeking Alpha
-
51jobs Q3 2009 Earnings Call Transcript
on Nov 23, 2009about JOBS
-
NetEase Q3 2009 Earnings Call Transcript
on Nov 18, 2009about NTES
-
Franklin Covey Co. F4Q09 (Qtr End 08/31/09) Earnings Call Transcript
on Nov 16, 2009about FC
-
Cellcom Israel Ltd. Q3 2009 Earnings Call Transcript
on Nov 16, 2009about CEL
-
URS Corporation Q3 2009 Earnings Call Transcript
on Nov 13, 2009about URS
IndustryTop Rated
